May 3, 2021
RFA-AI-20-078 - Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
This Notice announces the participation of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in RFA-AI-20-078" Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)", effective immediately.
The following sections of RFA-AI-20-078 have been modified (changes shown in bold italics) to reflect the participation of NICHD in this Funding Opportunity Announcement (FOA):
Part 1. Overview Information
Components of Participating Organizations
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Environmental Health Sciences (NIEHS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.855; 93.113, 93.865
All other aspects of the FOA remain unchanged.
Sai P. Majji, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-402-8048
Email: [email protected]